EoETaly Guidelines Part-2

*If clinically visible, the achievement of histological remission before proceeding to esophageal dilatation is advisable.
†Assessment of poor esophageal distensibility by means of esophageal panometry before dilatation is advisable.

ABBREVIATIONS:
b.i.d., twice a day; BOT, budesonide orally disintegrating tablet; FFED, four-food elimination diet; GERD, gastroesophageal reflux disease; PPIs, proton pump inhibitors; OFED, one-food elimination diet; SFED, six-food elimination diet; TFED, two-food elimination diet; Th2, T-helper cell type 2.

REFERENCE:
de Bortoli N, Visaggi P, and Penagini R, et al. The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis-Current Treatment and Monitoring. Dig Liver Dis. 2024;56(7):1173-1184.